South Korea Antidote Market Size, Share, and COVID-19 Impact Analysis, By Type (Snake Antivenoms, Scorpion Antivenoms, Spider Antivenoms, Insect Antivenoms, and Other Animal Antivenoms), By Administration (Injection, Topical, and Oral), By End Use (Hospitals, Clinics, Animal Hospitals, Research Facilities, and Home Care Settings), By Source (Animal-Derived, Plant-Derived, Synthetic, and Recombinant), and South Korea Antidote Market Insights, Industry Trend, Forecasts to 2035.

South Korea Antidote Market Insights Forecasts to 2035

• The South Korea Antidote Market Size Was Estimated at USD 62.9 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 8.76% from 2025 to 2035
• The South Korea Antidote Market Size is Expected to Reach USD 158.4 Million by 2035

According to a research report published by Spherical Insights & Consulting, The South Korea Antidote Market is Size Anticipated to reach USD 158.4 Million By 2035, Growing at a CAGR of 8.76% from 2025 to 2035. The market for antidotes is anticipated to rise in the upcoming years due to an increase in poisoning events. When individual are exposed to, consume, or come into touch with substances that are harmful to their health, poisoning incidents happen. In these circumstances, antidotes are essential because they neutralize the negative effects of hazardous chemicals. These antidotes counteract, lessen, or even reverse the harmful effects of toxins.

Market Overview

The demand and supply for pharmaceutical items intended to mitigate the negative consequences of poisonings or overdoses are included in the antidote market. These antidotes are used to neutralize poisonous substances and reduce long-term harm to the body in emergencies. Both chemical and biological antidotes, which each work through a separate mechanism to counter the effects of a poison. Antidote injections efficiently counteract toxins or pharmacological effects, providing prompt, accurate, and targeted treatment. They are extremely useful in emergencies since they neutralize the harmful effects of several drugs. One of the main causes is occupational poisoning, especially from pesticide exposure, and the increase in drug overdoses. Antidotes are used to treat several illnesses, such as toxoplasmosis, reversing opiate drowsiness, and pneumonia prophylaxis. To guarantee the security and effectiveness of antidotes, governments are enforcing more stringent regulations. This involves laying out precise procedures for new antidotes to be approved and keeping an eye on how well they sell. The quality of antidotes that patients and healthcare professionals have access to is enhanced by these restrictions. Governmental organizations and businesses are working together on clinical trials and research projects. The goal of these partnerships is to create novel antidotes and increase the potency of already existing ones. Research continues to be done to better understand poisoning mechanisms and create diagnostic tools.

Report Coverage

This research report categorizes the market for the South Korea antidote market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the South Korea antidote market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the South Korea antidote market.

Driving Factors

Antidotes are becoming more and more necessary as the frequency of poisonings, such as drug overdoses and snake bites, is rising worldwide. Improved diagnostic techniques and increased knowledge of the risks of poisoning enable earlier and more precise poisoning identification, which expedites the use of antidotes. Antidotes are becoming safer and more effective advancements in drug delivery systems and other technologies, which is increasing demand. The industry is also being driven by government funding for antidote research and development as well as regulatory approvals for novel or enhanced therapies. There is a growing desire from patients and medical professionals for antidotes that have fewer adverse effects in addition to being efficient at reversing the effects of poisoning.

Restraining Factors

When developing and permitting novel antidotes, the pharmaceutical industry must adhere to stringent standards, which can be costly and time-consuming. It can be quite expensive to conduct research and produce novel antidotes, particularly those that target particular toxins or new dangers. Certain antidotes are created for extremely particular poisons or poisonous animals, which restricts the market's potential size and makes it challenging for pharmaceutical firms to turn a profit.

Market Segmentation

The South Korea antidote market share is classified into type, administration, end-use, and source.

• The snake antivenoms segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea antidote market is segmented by type into snake antivenoms, scorpion antivenoms, spider antivenoms, insect antivenoms, and other animal antivenoms. Among these, the snake antivenoms segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. The need for efficient antivenoms is derived from the rising number of snakebite cases worldwide, especially in tropical and subtropical areas.

• The injection segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea antidote market is segmented by administration into injection, topical, and oral.  Among these, the injection segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. The rising incidence of serious illnesses that need prompt medical attention, like poisoning and snake bites, is the reason that is responsible for this segment's expansion.

• The hospitals segment held a dominated share in 2024 and is expected to grow at a substantial CAGR during the forecast period.

The South Korea antidote market is segmented by end-use into hospitals, clinics, animal hospitals, research facilities, and home care settings. Among these, the hospitals segment held a dominated share in 2024 and is expected to grow at a substantial CAGR during the forecast period. The large number of cases of envenomation that these clinics handle. They offer envenomation patients convenient and accessible care; clinics are also anticipated to play a major role in the market's expansion.

• The animal-derived segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.

The South Korea antidote market is segmented by source into animal-derived, plant-derived, synthetic, and recombinant. Among these, the animal-derived segment held the largest share in 2024 and is expected to grow at a substantial CAGR during the forecast period. This is because of its proven efficiency in neutralizing venom and toxins, especially in emergency treatments. Its high demand and established production methods help maintain its growth, while supported by clinical dependability and extensive usage in hospitals and poison control centers.

 Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the South Korea antidote market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Celltrion Inc. 
• Samsung Biologics
• LG Chem Ltd
• Yuhan Corporation
• GC Biopharma Corp
• Hanmi Pharmaceutical Co., Ltd.
• Chong Kun Dang Pharmaceutical Corp
• Daewoong Pharmaceutical Co., Ltd.
• Dong-A Pharmaceutical Co., Ltd.
• SK Biopharmaceuticals Co., Ltd.
• SK Bioscience Ltd
• Others

Recent Development: 

• In February 2025, Daewoong Pharmaceutical (Co-CEOs Seongsoo Park and Chang-Jae Lee), a premier Korean healthcare firm, officially launched its high-purity, high-quality botulinum toxin product, NABOTA, in Saudi Arabia.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the South Korea antidote market based on the below-mentioned segments

South Korea Antidote Market, by Type

• Snake Antivenoms
• Scorpion Antivenoms
• Spider Antivenoms
• Insect Antivenoms
• Other Animal Antivenoms

South Korea Antidote Market, By Administration

• Injection
• Topical
• Oral

South Korea Antidote Market, By End Use

• Hospitals
• Clinics
• Animal Hospitals
• Research Facilities
• Home Care Settings

South Korea Antidote Market, By Source

• Animal-Derived
• Plant-Derived
• Synthetic
• Recombinant